During the AcrySof® ReSTOR®
IOL clinical studies, patients experienced lifestyle enhancement through quality
vision, and greater freedom from reading glasses and bifocals. In fact,
according to the AcrySof® ReSTOR® clinical studies, four out of five patients with the AcrySof® ReSTOR® IOL reported never wearing glasses following cataract surgery in both eyes, compared to only 1 out of 10 patients with monofocal lenses. This is the highest level of freedom from glasses ever demonstrated in an IOL clinical trial.
Additionally, the AcrySof® ReSTOR® clinical studies indicated that nearly 94% of the study subjects were so satisfied with their new quality vision that they would have the AcrySof® ReSTOR® IOL implanted again.
Copyright © 2012 Novartis AG a global company based in Basel, Switzerland. The information and materials within this section pertain to the U.K. market only. Not all products are approved in every marked and approved labeling and instructions may vary by local country. See the Alcon Privacy Policy and Terms & Conditions for the use of this site.